Softsol India Shareholders Approve Aravind Kumar Madala as New Managing Director

1 min read     Updated on 17 Nov 2025, 02:07 PM
scanx
Reviewed by
Ashish TScanX News Team
Overview

Softsol India Limited shareholders have approved the appointment of Aravind Kumar Madala as Director and Managing Director through a postal ballot. Madala's five-year term as Managing Director is effective from September 1, 2025, with a fixed salary of Rs. 2,00,000 per month for the first three years. The appointment received near-unanimous shareholder approval, with 45,61,284 votes in favor and only 1 vote against.

24914253

*this image is generated using AI for illustrative purposes only.

Softsol India Limited , a prominent player in the Indian IT sector, has announced a significant change in its leadership structure. Shareholders of the company have approved the appointment of Mr. Aravind Kumar Madala as both Director and Managing Director through a postal ballot voting process that concluded on November 15, 2025.

Key Highlights of the Appointment

  • Appointment Duration: Mr. Madala has been appointed for a five-year term as Managing Director.
  • Effective Date: The appointment is effective from September 1, 2025.
  • Remuneration Details:
    • Fixed salary of Rs. 2,00,000 per month for the first three years.
    • Additional benefits include contributions to Provident Fund, Superannuation Fund, and gratuity.

Shareholder Approval Details

The appointment received overwhelming support from shareholders, as evidenced by the voting results:

Particulars Number of Members Voted Number of Votes Cast Percentage of Valid Votes
Total Valid Votes 42 45,61,285 100.00%
Votes in Favor 41 45,61,284 100.00%
Votes Against 1 1 0.00%

Corporate Governance Implications

This appointment marks a significant change in Softsol India's leadership structure. The company has followed due process in accordance with the Companies Act, 2013, and SEBI regulations. The strong shareholder support suggests confidence in Mr. Madala's ability to lead the company.

About the Appointment Process

The appointment was made following recommendations from the Nomination and Remuneration Committee, Audit Committee, and Board of Directors. It complies with various regulatory requirements, including:

  • Sections 152, 161, 196, 197, and 203 of the Companies Act, 2013
  • Regulation 17 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

The comprehensive approval process and the strong shareholder support indicate a well-planned transition in Softsol India's top management.

Historical Stock Returns for Covance Softsol

1 Day5 Days1 Month6 Months1 Year5 Years
+1.97%+10.35%+51.27%+1,082.82%+5,595.06%+5,595.06%
Covance Softsol
View in Depthredirect
like17
dislike

SoftSol India Seeks Shareholder Approval for Aravind Kumar Madala's Appointment as Managing Director

1 min read     Updated on 15 Oct 2025, 03:12 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

SoftSol India Limited, a real estate and property leasing company, is seeking shareholder approval for the appointment of Dr. Aravind Kumar Madala as Director and Managing Director. The proposed five-year term runs from September 1, 2025, to August 31, 2030, with a fixed salary of Rs. 2,00,000 per month for the first three years. Dr. Madala, a General Physician with 19 years of experience, brings healthcare administration and leadership expertise to the role. E-voting for shareholders is scheduled from October 17 to November 15, 2025.

22066949

*this image is generated using AI for illustrative purposes only.

Softsol Limited, a real estate and property leasing company, has announced a significant change in its leadership structure. The company is seeking shareholder approval for the appointment of Dr. Aravind Kumar Madala as a Director and Managing Director through a postal ballot notice.

Key Appointments and Resolutions

SoftSol India has proposed two resolutions for shareholder approval:

  1. Appointment of Dr. Aravind Kumar Madala as a Director of the company.
  2. Appointment of Dr. Madala as the Managing Director for a five-year term from September 1, 2025, to August 31, 2030.

About Dr. Aravind Kumar Madala

Dr. Madala brings a unique blend of medical expertise and management experience to SoftSol India:

  • General Physician with over 19 years of experience
  • Completed medical education at Kasturba Medical College, Mangalore (1996-2006)
  • Experience in healthcare administration
  • Strong background in leadership and management

Proposed Remuneration and Terms

The company has outlined the following terms for Dr. Madala's appointment:

Aspect Details
Tenure 5 years (September 1, 2025 to August 31, 2030)
Remuneration Period 3 years (September 1, 2025 to August 31, 2028)
Fixed Salary Rs. 2,00,000 per month
Additional Benefits Provident Fund, Superannuation Fund, Gratuity, Leave Encashment

Voting Process

SoftSol India has initiated an e-voting process for these resolutions:

  • E-voting period: October 17, 2025 (9:00 AM IST) to November 15, 2025 (5:00 PM IST)
  • Results to be declared within 48 hours of the conclusion of e-voting

Company Background

SoftSol India Limited, with its registered office in Hyderabad, is primarily engaged in real estate-related activities, including leasing of properties or spaces. The company reported a total revenue of Rs. 1866.85 lakhs and a net profit of Rs. 863.56 lakhs for the financial year 2024-2025.

This strategic move by SoftSol India to bring Dr. Madala on board as Managing Director could potentially bring a fresh perspective to the company's operations, given his diverse background in healthcare and administration. Shareholders will play a crucial role in determining the company's future direction through their votes on these significant appointments.

Historical Stock Returns for Covance Softsol

1 Day5 Days1 Month6 Months1 Year5 Years
+1.97%+10.35%+51.27%+1,082.82%+5,595.06%+5,595.06%
Covance Softsol
View in Depthredirect
like17
dislike
More News on Softsol
Explore Other Articles
92.26
+1.78
(+1.97%)